Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Revenues Up 2 Percent in Q4, Losses Narrow 18 Percent

NEW YORK, Feb. 19 (GenomeWeb News) - Gene Logic today reported a 2-percent increase in total revenues and a 6.5-percent decrease in net losses year over year.

 

Total revenue for the three month period ended Dec. 31, 2004, increased to $20 million $19.7 million for the year-ago period.

 

Gene Logic said it spent $967,000 on R&D in the quarter, up from $491,000 year over year.

 

Net loss for the quarter fell 18 percent to $4 million, or $.13 per share, from $4.9 million, or $.16 per share.

 

Cash and cash equivalents on hand as of Dec. 31 included $53 million and $50 million in marketable securities.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.